Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New female condom tested against market leader

NCT ID NCT06821152

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a new female condom called Miss Liberty against the existing FC2 female condom. 235 women aged 18-45 used each condom five times in a random order. Researchers measured breakage, slippage, and other failures to see if Miss Liberty works as well as FC2. They also checked safety and how much women liked using it.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Miss Liberty female condom (polyurethane device with two flexible rings)
What this could lead to
If successful, this could provide a safe and acceptable alternative female condom option for pregnancy and STI prevention.
What could go wrong
This is a completed device comparison study, not a treatment trial. Results may show no significant difference or lower performance than FC2.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

235 people

The number who actually took part.

Started

May 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be between the ages of 18 and 45 years (inclusive); * Be of female sex and gender * Be literate (able to read a newspaper or letter easily); * Have been in an exclusive (monogamous) heterosexual sexual relationship with a male partner partner for at least 3 months; and intend to continue to be an exclusive (monogamous) sexual relationship with their spouse or partner while participating in this research study; * Be sexually active (defined as having at least one vaginal coital act per week); * Willing to give informed consent; * Willing to complete the female condom coital use reports; * Willing to use the study condoms as directed; * Agree to only use the study condoms sequentially during time of participation * Willing to adhere to the follow-up schedule and all study procedures; * Willing to provide research study staff with an address, phone number or other locator information while participating in the study; * Willing to participate in the study for the duration of 10 condom uses (approximately 2- 3 months); * Willing to have a fingerprint scan to exclude co-enrolment in other research projects; * Using hormonal or other non-barrier contraception (e.g. Oral Contraceptives, injectables, implant, Intrauterine device (IUD), or have had a tubal sterilization) or male partner vasectomised; * Agree to return any unopened condoms; * Agree to not bring study condoms in contact with genital or oral piercing jewelry; * Able to understand instructions for correct use of female condoms; * Agree not to use male condoms when using the female condom in a single sex act. Exclusion Criteria: * Woman is pregnant or desires to become pregnant during the time of the research study; * Known to be HIV positive by self report; * Self-reported history of current sexually transmitted infection (e.g. gonorrhea, syphilis, Chlamydia); * Female (or reports her partner) has genital piercing jewelry, uses genital beading or uses sex toys, drugs, medications or non-study devices that can affect sexual performance; * Female (or reports her partner) has known sensitivities or allergies to latex, synthetic nitrile, vaginal/sexual lubricants or lubricants used on condoms; * Female has symptoms of a sexually transmitted infection (STI). * Male partner has known erectile or ejaculatory dysfunction; * Is a past or current employee of the University of the Witwatersrand or Miss Liberty Ltd;

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Functional performance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • MatCH Research Unit [Maternal, Adolescent and Child Health Research Unit]

    Durban, KwaZulu-Natal, 4001, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.